Skip to content

Examination of the immunostimulatory effects of research food intake

Examination of the immunostimulatory effects of research food intake - Examination of the immunostimulatory effects of research food intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043100
Enrollment
10
Registered
2022-04-12
Start date
2021-01-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake research food for 8 consecutive weeks

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy males and females from 20 to 64 years of age with lower secretory IgA in saliva.

Exclusion criteria

Exclusion criteria: (1) Subjects who routinely use health food containing specific ingredients (ex. Resistant dextrin, Polydextrose, Resistant glucan etc. ). (2) Subjects who constantly use medications affecting the immune system. (3) Subjects who constantly use supplements and/or functional foods affecting the immune system. (4) Subjects who intend to get vaccinated within 4 weeks or done. (5) Subjects who have symptoms that affect the performance of the test. (6) Subjects who get treatment affecting the test results. (7) Night and day shift worker or manual laborer (8) Subjects who habitually do intense exercise such as marathon. (9) Subjects who cannot carry out inspection procedure as prescribed (10) Subjects who are judged as having serious diseases (11) Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease) and disease to affect the adrenal cortical hormone secretion (12) Subjects having possibilities for emerging allergy related to the study (13) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (14) Subjects who intend to become pregnant or lactating (15) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (16) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (17) Subjects judged as unsuitable for the study by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
secretory IgA concentration in saliva, secretory IgA flow rate in saliva

Secondary

MeasureTime frame
QOL questionnaire, fatigue questionnaire

Countries

Japan

Contacts

Public ContactKei Yasui

EP Mediate Co., Ltd. Clinical Research Planning Department

yasui475@eps.co.jp03-5657-4983

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026